Analyst Ratings for Twist Bioscience
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for Twist Bioscience (NASDAQ:TWST) in the last quarter, with 2 somewhat bullish, 3 indifferent, and no bearish ratings. The average 12-month price target for the stock is $19.6, representing a 40.61% decrease from the previous average price target of $33.00.
July 13, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Twist Bioscience has received mixed ratings from analysts, with a lower average price target suggesting potential downside.
The mixed analyst ratings, combined with a significantly lower average price target, suggest that analysts see potential downside for Twist Bioscience. This could negatively impact the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100